Skip to main content

Table 4 Contents of β-artemether and lumefantrine in fixed dose combination (FDC) products (n=6)

From: A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products

FDC samples Batch/Lot No. Content (%) ± S.D.
   β-artemether Lumefantrine
Artemine® tablets A 103.2 ± 1.5 101.5 ± 0.9
  B 102.2 ± 1.7 101.3 ± 0.5
Coartem® tablets A 98.2 ± 0.9 97.92 ± 0.7
  B 99.2 ± 1.5 98.8 ± 0.7
Co-Artesiane powder for oral suspension A 100.9 ± 1.9 101.4 ± 0.9
B 99.7 ± 1.6 102.0 ± 0.8
C 101.1 ± 1.3 100.8 ± 0.8
  1. S.D. = standard deviation.